Alimera Sciences, Inc.

Alimera Sciences, Inc.verified

ALIM

Price:

$2.95

Market Cap:

$154.55M

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2019-11-04

Stock Exchange

NASDAQ

Ticker

ALIM

The PE Ratio as of May 2024 (TTM) for Alimera Sciences, Inc. (ALIM) is -3.51

According to Alimera Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.51. This represents a change of -67.26% compared to the average of -10.72 of the last 4 quarters.

Alimera Sciences, Inc. (ALIM) Historical PE Ratio (quarterly & annually)

How has ALIM PE Ratio performed in the past?

The mean historical PE Ratio of Alimera Sciences, Inc. over the last ten years is -4.04. The current -3.51 PE Ratio has changed 8.60% with respect to the historical average. Over the past ten years (40 quarters), ALIM's PE Ratio was at its highest in in the June 2014 quarter at 53.95. The PE Ratio was at its lowest in in the September 2023 quarter at -18.38.

Quarterly (TTM)
Annual

Average

-4.04

Median

-3.78

Minimum

-7.74

Maximum

-1.05

Alimera Sciences, Inc. (ALIM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alimera Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 423.80%

Maximum Annual PE Ratio = -1.05

Minimum Annual Increase = -86.47%

Minimum Annual PE Ratio = -7.74

Quarterly (TTM)
Annual
YearPE RatioChange
2023-5.49423.80%
2022-1.05-86.47%
2021-7.7491.31%
2020-4.0516.83%
2019-3.4612.84%
2018-3.07-24.24%
2017-4.05135.60%
2016-1.72-51.03%
2015-3.51-43.68%
2014-6.2394.11%

Alimera Sciences, Inc. (ALIM) Average PE Ratio

How has ALIM PE Ratio performed in the past?

The current PE Ratio of Alimera Sciences, Inc. (ALIM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.76

5-year avg

-4.36

10-year avg

-4.04

Alimera Sciences, Inc. (ALIM) PE Ratio vs. Peers

How is ALIM’s PE Ratio compared to its peers?

Alimera Sciences, Inc.’s PE Ratio is less than Shuttle Pharmaceuticals Holdings, Inc. (-0.94), less than Lifecore Biomedical, Inc. (-2.66), less than Mallinckrodt plc (-0.00), greater than Journey Medical Corporation (-17.10), less than Lucy Scientific Discovery Inc. (-1.21), less than Adamis Pharmaceuticals Corporation (-0.47), less than Organogenesis Holdings Inc. (23.50), less than Cyclo Therapeutics, Inc. (-1.99), less than Athenex, Inc. (-0.03), less than MedMen Enterprises Inc. (-0.00), less than China Pharma Holdings, Inc. (-1.09), less than Halo Collective Inc. (-0.00), less than China SXT Pharmaceuticals, Inc. (-0.03), less than Petros Pharmaceuticals, Inc. (-0.20),

Build a custom stock screener for Alimera Sciences, Inc. (ALIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alimera Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alimera Sciences, Inc. (ALIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alimera Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Alimera Sciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Alimera Sciences, Inc. (ALIM)?

What is the highest PE Ratio for Alimera Sciences, Inc. (ALIM)?

What is the 3-year average PE Ratio for Alimera Sciences, Inc. (ALIM)?

What is the 5-year average PE Ratio for Alimera Sciences, Inc. (ALIM)?

How does the current PE Ratio for Alimera Sciences, Inc. (ALIM) compare to its historical average?